Compare Ascendis Pharma A/S (ASND) vs Cytokinetics Inc (CYTK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ascendis Pharma A/S vs Cytokinetics Inc — how do they compare? Ascendis Pharma A/S trades at $254.5 (market cap $16.67B), while Cytokinetics Inc trades at $76.67 (market cap $10.63B). The key difference: Ascendis Pharma A/S is the larger of the two by market cap. Which is the better fit depends on your goals.
| ASND | CYTK | |
|---|---|---|
Market Cap | $16.67B | $10.63B |
Sector | Health | Technology |
52-Week High | $277.18 | $87.26 |
52-Week Low | $189.74 | $34.31 |
Enterprise Value | $17.04B | $10.74B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →
